Consumer health companyLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field. in United StatesLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field.. FDA records under its name, each linked to the record.
As of Nov 14, 2026, FDA's public records list Advanced Nutriceuticals with 17 drug recalls. The most recent is a drug recall dated Nov 30, 2020: BPC-157, 2000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis….
Drug approvals, 510(k) clearances, recalls and letters, 2017 to 2026 to date
A hatched bar is a year that is not over, so its count covers only part of the year.
| Nov 30, 2020 | BPC-157, 2000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, INClass II · Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products inte | Drug recalls |
| Nov 30, 2020 | GHRP, 2000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, INClass II · Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products inte | Drug recalls |
| Nov 30, 2020 | THYMOSIN ALPHA, 2000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, INClass II · Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products inte | Drug recalls |
| Nov 30, 2020 | LL-37, 2000 MCG/ML, 2 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, INClass II · Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products inte | Drug recalls |
| Nov 30, 2020 | AOD-9604, 1200 MCG/ML, 5 ML vial The Guyer Institute of Molecular Medicine, Indianapolis, INClass II · Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products inte | Drug recalls |
| Nov 30, 2020 | CEREBROLYSIN, 107.5 MG/ML, 10 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, INClass II · Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products inte | Drug recalls |
| Nov 30, 2020 | THYMOSIN BETA - 4, 2000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, INClass II · Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products inte | Drug recalls |
| Nov 30, 2020 | HIGH DOSE B12, 10 MG/ML, 10 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, INClass II · Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products inte | Drug recalls |
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata. How this page is built
